Haiyan Xu
- Oncology top 5%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Endocrine and Autonomic Systems top 1%
- Plant Science top 10%
- Co-authors
- Andrew C. LiuYan WangMaki Ukai‐TadenumaHiroki R. UedaSanjoy K. KhanGuangjian YangLu YangJürgen A. Ripperger
- Topics
- Lung Cancer Treatments and Mutations (44 papers)Lung Cancer Research Studies (22 papers)Cancer Immunotherapy and Biomarkers (15 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Haiyan Xu
109 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 131
- Oncology 858
- Molecular Biology 739
- Pulmonary and Respiratory Medicine 658
- Endocrine and Autonomic Systems 650
- Plant Science 329
Countries citing papers authored by Haiyan Xu
This map shows the geographic impact of Haiyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Xu more than expected).
Fields of papers citing papers by Haiyan Xu
This network shows the impact of papers produced by Haiyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Xu. The network helps show where Haiyan Xu may publish in the future.
Co-authorship network of co-authors of Haiyan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Haiyan Xu. A scholar is included among the top collaborators of Haiyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyan Xu. Haiyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 8 | |
| 7 | 3 | |
| 8 | 55 | |
| 9 | 99 | |
| 10 | 3 | |
| 11 | 8 | |
| 12 | 25 | |
| 13 | 5 | |
| 14 | 24 | |
| 15 | 31 | |
| 16 | 11 | |
| 17 | 75 | |
| 18 | 13 | |
| 19 | 45 | |
| 20 | 18 |
About Haiyan Xu
Haiyan Xu is a scholar working on Oncology, Endocrine and Autonomic Systems and Pulmonary and Respiratory Medicine, having authored 116 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (44 papers), Lung Cancer Research Studies (22 papers) and Cancer Immunotherapy and Biomarkers (15 papers). The work is most often cited by research in Endocrine and Autonomic Systems (650 citations), Aging (151 citations) and Oncology (858 citations). Haiyan Xu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Andrew C. Liu, Yan Wang, Maki Ukai‐Tadenuma, Hiroki R. Ueda, Sanjoy K. Khan, Guangjian Yang, Lu Yang, Jürgen A. Ripperger, Rikuhiro G. Yamada and Chidambaram Ramanathan. Their work appears in journals such as Cell, Journal of Biological Chemistry and Neuron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.